TREU JESSE I

10% owner at IOMAI CORP · on record since Jan 25, 2006
Director at Somaxon Pharmaceuticals, Inc. · on record since Feb 1, 2006
10% owner at Somaxon Pharmaceuticals, Inc. · on record since Feb 1, 2006
10% owner at SANTARUS INC · on record since Mar 31, 2004
10% owner at Volcano CORP · on record since Jun 20, 2006
Director at VERACYTE, INC. · on record since Oct 29, 2013
10% owner at VERACYTE, INC. · on record since Oct 29, 2013
10% owner at Vanda Pharmaceuticals Inc. · on record since Apr 18, 2006
10% owner at NOVACEA INC · on record since May 16, 2006
Director at Northstar Neuroscience, Inc. · on record since May 11, 2006
10% owner at Northstar Neuroscience, Inc. · on record since May 11, 2006
10% owner at CADENCE PHARMACEUTICALS INC · on record since Oct 30, 2006
Director at SENORX INC · on record since Mar 28, 2007
10% owner at SENORX INC · on record since Mar 28, 2007
10% owner at Orexigen Therapeutics, Inc. · on record since Apr 25, 2007
10% owner at NUVASIVE INC · on record since May 12, 2004
10% owner at Clovis Oncology, Inc. · on record since Nov 21, 2011
Director at INSPIRE PHARMACEUTICALS INC · on record since Jul 16, 2003
10% owner at · on record since Apr 27, 2010
10% owner at · on record since Aug 23, 2010
10% owner at · on record since Nov 22, 2010
Director at · on record since Nov 19, 2013
10% owner at · on record since Nov 19, 2013
10% owner at · on record since Dec 20, 2010
10% owner at · on record since Jun 17, 2004
10% owner at · on record since Jul 24, 2012
10% owner at · on record since Jan 15, 2013
10% owner at · on record since Jun 25, 2013
10% owner at · on record since Jul 31, 2013
10% owner at · on record since Sep 30, 2013
Director at · on record since Aug 28, 2013
10% owner at · on record since Aug 28, 2013
10% owner at · on record since Jan 29, 2014
10% owner at · on record since Mar 17, 2014
Director at · on record since May 7, 2014
10% owner at · on record since May 7, 2014
10% owner at · on record since Jul 31, 2014
10% owner at · on record since Aug 18, 2014
10% owner at · on record since Oct 14, 2016
10% owner at · on record since Nov 26, 2014
10% owner at · on record since Oct 21, 2014
10% owner at · on record since Oct 6, 2004
10% owner at · on record since Jun 24, 2015
10% owner at · on record since May 12, 2015
Director at · on record since May 11, 2015
10% owner at · on record since May 11, 2015
10% owner at · on record since Mar 8, 2016
10% owner at · on record since Aug 27, 2018
10% owner at · on record since May 13, 2019

Insider trading activity of TREU JESSE I

Transactions on record: 566; since Apr 8, 2004

Open-market buys: 65; $114.3M

Open-market sells: 93; $99.4M

Companies traded: 31; last filing Jun 11, 2020

Figures computed from official regulatory filings — .

Companies where TREU JESSE I has traded

17 tx · $968.4K · Jun 11, 2020
27 tx · $26.9M · Mar 4, 2019
1 tx · $3M · Aug 27, 2018
7 tx · $16M · Dec 13, 2017
16 tx · Nov 17, 2016
7 tx · $108.9K · Apr 27, 2016
4 tx · May 12, 2015
9 tx · $4M · May 11, 2015
11 tx · $4M · Mar 24, 2015
18 tx · $3M · Jan 5, 2015
47 tx · $183.3M · Mar 21, 2014
8 tx · Mar 17, 2014
10 tx · Feb 4, 2014
15 tx · $4.2M · Jun 13, 2013

Track record of TREU JESSE I

Statistical track record

Free

Open-market buys: 72

Last buy: Aug 23, 2018

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of TREU JESSE I

Co-insiders of TREU JESSE I

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Aldeyra Therapeutics, Inc.	Jun 11, 2020	AwardD (derivative)	26,503	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 11, 2020	AwardD (derivative)	2,465	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 11, 2020	AwardD (derivative)	2,311	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 6, 2019	AwardD (derivative)	1,653	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 6, 2019	AwardD (derivative)	1,763	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 6, 2019	AwardD (derivative)	18,951	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Mar 28, 2019	Sell	-445	10.01 USD	$4.5K	SEC
Aldeyra Therapeutics, Inc.	Mar 28, 2019	Sell	-96,298	10.01 USD	$963.9K	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-12,193	20.21 USD	$246.4K	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-272,977	20.45 USD	$5.6M	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-414,958	20.21 USD	$8.4M	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-2,381	20.44 USD	$48.7K	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-207	21.24 USD	$4.4K	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-2,023	20.45 USD	$41.4K	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-319,619	20.44 USD	$6.5M	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-27,793	21.24 USD	$590.3K	SEC
OBALON THERAPEUTICS INC	Aug 27, 2018	Buy	1,648,359	1.82 USD	$3M	SEC
VERACYTE, INC.	Aug 2, 2018	Sell	-119,112	10.85 USD	$1.3M	SEC
VERACYTE, INC.	Aug 2, 2018	Sell	-2,812	10.82 USD	$30.4K	SEC
VERACYTE, INC.	Aug 2, 2018	Sell	-888	10.85 USD	$9.6K	SEC
VERACYTE, INC.	Aug 2, 2018	Sell	-377,188	10.82 USD	$4.1M	SEC
Aldeyra Therapeutics, Inc.	Jun 11, 2018	AwardD (derivative)	1,354	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 11, 2018	AwardD (derivative)	1,444	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 11, 2018	AwardD (derivative)	15,526	0.00 USD	—	SEC
VERACYTE, INC.	Jun 8, 2018	AwardD (derivative)	10,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Aldeyra Therapeutics, Inc.	Jun 11, 2020	AwardD (derivative)	26,503	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 11, 2020	AwardD (derivative)	2,465	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 11, 2020	AwardD (derivative)	2,311	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 6, 2019	AwardD (derivative)	1,653	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 6, 2019	AwardD (derivative)	1,763	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 6, 2019	AwardD (derivative)	18,951	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Mar 28, 2019	Sell	-445	10.01 USD	$4.5K	SEC
Aldeyra Therapeutics, Inc.	Mar 28, 2019	Sell	-96,298	10.01 USD	$963.9K	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-12,193	20.21 USD	$246.4K	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-272,977	20.45 USD	$5.6M	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-414,958	20.21 USD	$8.4M	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-2,381	20.44 USD	$48.7K	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-207	21.24 USD	$4.4K	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-2,023	20.45 USD	$41.4K	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-319,619	20.44 USD	$6.5M	SEC
VERACYTE, INC.	Mar 4, 2019	Sell	-27,793	21.24 USD	$590.3K	SEC
OBALON THERAPEUTICS INC	Aug 27, 2018	Buy	1,648,359	1.82 USD	$3M	SEC
VERACYTE, INC.	Aug 2, 2018	Sell	-119,112	10.85 USD	$1.3M	SEC
VERACYTE, INC.	Aug 2, 2018	Sell	-2,812	10.82 USD	$30.4K	SEC
VERACYTE, INC.	Aug 2, 2018	Sell	-888	10.85 USD	$9.6K	SEC
VERACYTE, INC.	Aug 2, 2018	Sell	-377,188	10.82 USD	$4.1M	SEC
Aldeyra Therapeutics, Inc.	Jun 11, 2018	AwardD (derivative)	1,354	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 11, 2018	AwardD (derivative)	1,444	0.00 USD	—	SEC
Aldeyra Therapeutics, Inc.	Jun 11, 2018	AwardD (derivative)	15,526	0.00 USD	—	SEC
VERACYTE, INC.	Jun 8, 2018	AwardD (derivative)	10,000	0.00 USD	—	SEC